Get started
Author

Chance C. Sine

Observed names: Chance Sine, Sine, Chance
ORCID: 0000-0002-7184-146X
Observed ORCID: 0000-0002-7184-146X
OpenAlex ID: A5039187140
p21 produces a bioactive secretome that places stressed cells under immunosurveillance
2021 · Ines Sturmlechner, Cheng Zhang, et al. · Science · 291
Senescent cells limit p53 activity via multiple mechanisms to remain viable
2022 · Ines Sturmlechner, Chance C. Sine, et al. · Nature Communications · 45
PDF
Acute multi-level response to defective de novo chromatin assembly in S-phase
2024 · Jan Dreyer, Giulia Ricci, et al. · Molecular Cell · 18
PDF
p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1–driven ovarian cancers
2025 · Chance C. Sine, Lotte P. Watts, et al. · Science Signaling · 12
PDF
Acute multi-level response to defective de novo chromatin assembly in S-phase
2024 · Jan Dreyer, Giulia Ricci, et al. · Molecular Cell · 10
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors
2024 · Annapoorna Venkatachalam, Cristina Correia, et al. · Molecular Cancer · 5
PDF
Acute multi-level response to defective de novo chromatin assembly in S-phase
2024 · Jan Dreyer, Giulia Ricci, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 5328: p16 confers sensitivity to CDK2 inhibitors in CCNE1-amplified ovarian cancers
2025 · Chance Sine, Lotte Watts, et al. · Cancer Research
Abstract 1832: CHK1 inhibitor prexasertib induces NOXA-dependent apoptosis in ovarian cancer
2022 · Annapoorna Venkatachalam, Kevin L. Peterson, et al. · Cancer Research
Works count: 10
Citation count: 382
H-index: 5
I10-index: 5
Year
Topic
Type